Reproductive Endocrinology Ovulation Physiology

Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment

Roozenburg BJ, van Dessel HJ, Evers JL, Bots RS

Published August 1997 Human Reproduction (Oxford, England), 12(8), 1720-1722
DOI 10.1093/humrep/12.8.1720 PMID 9308800

RRM Academy Synopsis

Naltrexone, alone or with clomiphene, induced ovulation in 19 of 22

Naltrexone, alone or with clomiphene, led to ovulation in 19 out of 22 women. All 22 had not responded to clomiphene alone. This 1997 Dutch case series treated women with absent or rare periods. Twelve of the 19 got pregnant, all with one baby.

Study at a glance, case series of 22 women: Naltrexone, alone or with clomiphene, led to ovulation in 19 of 22 women
Study at a glance, case series of 22 women: Naltrexone, alone or with clomiphene, led to ovulation in 19 of 22 women. Source: Roozenburg BJ et al., 1997, PMID 9308800.

Key Findings

  • Ovulation was achieved in 19 of 22 women. Four ovulated on naltrexone alone.
  • Twelve women became pregnant during treatment, all with singleton pregnancies: three in the first cycle, four in the second, two in the third, two in the fourth, one in the fifth.
  • The median number of menstrual periods per year changed from 0.5 (range 0 to 6) before treatment to 11.5 (range 0 to 13.5) after.
  • Two spontaneous abortions had occurred and 10 pregnancies were ongoing when the paper went to press.
  • Three women did not respond to the combined treatment. All three had polycystic ovarian disease.

Interpretation

This case series followed 22 women treated between January 1995 and September 1996 at one fertility division, all previously unresponsive to clomiphene alone. The authors excluded women with high prolactin, thyroid problems, tubal damage or a low partner sperm count. The authors call naltrexone safe, simple and inexpensive compared with gonadotrophin treatment. Some women felt dizzy, anxious or restless in the first days of treatment. The findings support larger studies of this approach.

RRM Context

Restorative Reproductive Medicine looks for the reason ovulation fails. The authors suggest that in some clomiphene-resistant women, natural opioids in the brain may suppress the signal that drives ovulation. Blocking those receptors may restore it.

Abstract

Patients suffering from normogonadotrophic anovulation and infertility are initially treated with clomiphene citrate. Those who do not respond to clomiphene citrate usually receive gonadotrophin treatment which is labour-intensive, expensive, and associated with an increased risk of multiple pregnancies and ovarian hyperstimulation syndrome. We treated 22 patients with clomiphene resistant normogonadotrophic anovulation with naltrexone (an opioid receptor blocker) alone or naltrexone in combination with an antioestrogen. In 19 patients ovulation and resumption of a regular menstrual cycle was achieved and in 12 out of 19 a singleton pregnancy was observed. In conclusion, ovulation can be induced successfully using naltrexone alone or naltrexone in combination with an anti-oestrogen in clomiphene citrate resistant anovulatory patients. Compared to gonadotrophin induction of ovulation, this method is safe, simple and inexpensive.

Topics

By this author

Related research

Reproductive Endocrinology › Ovulation Physiology › Anovulation · Therapeutics › Ovulation Agents › Selective Estrogen Receptor Modulators · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
H J van Dessel
PMID 9308800 9308800 DOI 10.1093/humrep/12.8.1720 10.1093/humrep/12.8.1720 Roozenburg et al. 1997, Roozenburg 1997